Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
CEREW was delisted on the 30th of August, 2021.
29 hedge funds and large institutions have $14.6M invested in Cerevel Therapeutics Holdings, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
15% less funds holding
Funds holding: 34 → 29 (-5)
38% less capital invested
Capital invested by funds: $23.6M → $14.6M (-$8.93M)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$602K |
| 2 |
ES
Equitec Specialists
Chicago,
Illinois
|
+$70.1K |
| 3 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
+$65.3K |
| 4 |
BlackRock
New York
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.31M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.28M |
| 3 |
ACM
Altium Capital Management
New York
|
-$365K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$287K |
| 5 |
MCM
Moore Capital Management
New York
|
-$94K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DCM
26
Dupont Capital Management
Wilmington,
Delaware
| $56K | – | – | – |
|
27
TD Asset Management
Toronto,
Ontario, Canada
| $52K | – | – | – |
|
28
Verition Fund Management
Greenwich,
Connecticut
| $50K | – | – | – |
|
29
Morgan Stanley
New York
| $6K | – | – | – |
|
30
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
|
NCM
31
Nantahala Capital Management
New Canaan,
Connecticut
| – | -$4.31M | -283,332 | Closed |
|
|
32
Alyeska Investment Group
Chicago,
Illinois
| – | -$1.28M | -233,334 | Closed |
|
33
Walleye Capital
New York
| – | -$399 | -70,649 | Closed |
|
|
ACM
34
Altium Capital Management
New York
| – | -$365K | -64,666 | Closed |
|
|
MCM
35
Moore Capital Management
New York
| – | -$94K | -16,666 | Closed |
|
|
SM
36
SG3 Management
Dorado,
Puerto Rico
| – | -$43K | -7,666 | Closed |
|
|
WAM
37
Wolverine Asset Management
Chicago,
Illinois
| – | -$4K | -833 | Closed |
|
CEREW Hedge Fund Activity: Q1 2021 in Review
29 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) for Q1 2021, worth a combined $14.6M — down 38% from $23.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CEREW and 2 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $602K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $4.31M sold.
- 29 institutional investors held Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) as of Q1 2021, down from 34 in Q4 2020.
- Funds reported $14.6M of Cerevel Therapeutics Holdings, Inc. Warrant stock for Q1 2021, down 38% quarter-over-quarter.
- 2 funds opened new Cerevel Therapeutics Holdings, Inc. Warrant positions in Q1 2021 and 7 closed out, a net change of -5 holders.
- The largest Cerevel Therapeutics Holdings, Inc. Warrant buyer in Q1 2021 was Perceptive Advisors, an estimated $602K added.
- The largest Cerevel Therapeutics Holdings, Inc. Warrant seller in Q1 2021 was Nantahala Capital Management, an estimated $4.31M sold.
Based on aggregated 13F filings for Q1 2021.